Skip to main content
Erschienen in: Journal of Nuclear Cardiology 4/2018

01.08.2018 | Original Article

Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results

verfasst von: Malgorzata Kobylecka, MD, PhD, Monika Budnik, MD, Janusz Kochanowski, MD, PhD, Radoslaw Piatkowski, MD, PhD, Marek Chojnowski, MD, Katarzyna Fronczewska-Wieniawska, MD, PhD, Tomasz Mazurek, MD, PhD, Joanna Maczewska, MD, Michał Peller, MD, Grzegorz Opolski, MD, Prof, Leszek Krolicki, MD, Prof

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to assess the accumulation pattern of 18F-FDG in fasting patients with takotsubo cardiomyopathy (TTC) and to correlate the results with perfusion scintigraphy and echocardiography.

Methods

18 consecutive patients with TTC were identified by clinical symptoms, cardiac catheterization, and echocardiography. Coronary angiography (CA) and transthoracic echocardiography (TTE) were performed on the day of the onset of symptoms. An assessment of myocardial perfusion (99mTc-MIBI) and glucose metabolism (18F-FDG) was performed within 18 days.

Results

SPECT showed no regional perfusion abnormalities in 10/18 patients, and a mild perfusion defect was found in 8/18 patients. Perfusion abnormalities were limited to apical and para-apical regions. In 8/18 cases, there was an increased selective apical 18F-FDG accumulation. In 10/18 cases, in spite of the fastened 18F-FDG protocol, slightly inhomogeneous 18F-FDG uptake was present in the entire myocardium: with relatively reduced uptake of 18F-FDG in the apical region and LV mid-segments.

Conclusion

This study demonstrated the heterogeneous nature of myocardial 18F-FDG accumulation in patients with TTC. Selective, preferential apical 18F-FDG uptake in almost half of the patients confirms an existing disorder of glucose metabolism, similar to that observed in stunned or hibernated myocardium.
Literatur
1.
Zurück zum Zitat Obunai K, Misra D, Van Tosh A, Bergmann SR. Metabolic evidence of myocardial stunning in takotsubo cardiomyopathy: a positron emission tomography study. J Nucl Cardiol 2005;12:742-4.CrossRefPubMed Obunai K, Misra D, Van Tosh A, Bergmann SR. Metabolic evidence of myocardial stunning in takotsubo cardiomyopathy: a positron emission tomography study. J Nucl Cardiol 2005;12:742-4.CrossRefPubMed
2.
Zurück zum Zitat Feola M, Chauvie S, Rosso GL, Biggi A, Ribichini F. Bobbio M : Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study. J Nucl Cardiol 2008;15:811-7.CrossRefPubMed Feola M, Chauvie S, Rosso GL, Biggi A, Ribichini F. Bobbio M : Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study. J Nucl Cardiol 2008;15:811-7.CrossRefPubMed
3.
Zurück zum Zitat Bybee KA, Murphy J, Prasad A, Wright RS, Lerman A, Rihal CS, Chareonthaitawee PJ. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. Nucl Cardiol 2006;13:244-50.CrossRef Bybee KA, Murphy J, Prasad A, Wright RS, Lerman A, Rihal CS, Chareonthaitawee PJ. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. Nucl Cardiol 2006;13:244-50.CrossRef
4.
Zurück zum Zitat Yang MF, Jain D, He ZX. F-FDG cardiac studies for identifying ischemic memory. Curr Cardiovasc Imaging Rep 2012;5:383-9.CrossRef Yang MF, Jain D, He ZX. F-FDG cardiac studies for identifying ischemic memory. Curr Cardiovasc Imaging Rep 2012;5:383-9.CrossRef
5.
Zurück zum Zitat Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N. Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations. Eur J Nucl Med Mol Imaging 2014;41:384-93.CrossRefPubMed Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N. Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations. Eur J Nucl Med Mol Imaging 2014;41:384-93.CrossRefPubMed
6.
Zurück zum Zitat Myiachi H, Kumita S, Tanaka K. PET/CT and SPECT/CT cardiac fusion imaging in a patient with Takotsubo cardiomyopathy. Eur Heart J 2013;34(5):397.CrossRef Myiachi H, Kumita S, Tanaka K. PET/CT and SPECT/CT cardiac fusion imaging in a patient with Takotsubo cardiomyopathy. Eur Heart J 2013;34(5):397.CrossRef
7.
Zurück zum Zitat Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J 2008;155(3):408-17.CrossRefPubMed Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J 2008;155(3):408-17.CrossRefPubMed
8.
Zurück zum Zitat Vanoverschelde IL, Janier MF, Balcke JE, Marschll DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-94.PubMed Vanoverschelde IL, Janier MF, Balcke JE, Marschll DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-94.PubMed
9.
Zurück zum Zitat Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015;42(12):1929-40.CrossRefPubMedPubMedCentral Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015;42(12):1929-40.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Sadamatsu K, Tashiro H, Maehira N, Yamamoto K. Coronary microvascular abnormality in reversible systolic dysfunction observed after noncardiac disease. Jpn Circ 2000;64:789-92.CrossRef Sadamatsu K, Tashiro H, Maehira N, Yamamoto K. Coronary microvascular abnormality in reversible systolic dysfunction observed after noncardiac disease. Jpn Circ 2000;64:789-92.CrossRef
11.
Zurück zum Zitat Ako J, Takenaka K, Uno K, Nakamura F, Shoji T, Iijmia K, Ohike Y, Kim S, Watanabe T, Yoshizumi M, Ouchi Y. Reversible left ventricular systolic dysfunction-reversibility of coronary microvascular abnormality. Jpn Heart J 2001;42:355-63.CrossRefPubMed Ako J, Takenaka K, Uno K, Nakamura F, Shoji T, Iijmia K, Ohike Y, Kim S, Watanabe T, Yoshizumi M, Ouchi Y. Reversible left ventricular systolic dysfunction-reversibility of coronary microvascular abnormality. Jpn Heart J 2001;42:355-63.CrossRefPubMed
12.
Zurück zum Zitat Yoshida T, Hibino T, Kako N. A pathophysiologic study of Tako-Tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J 2007;28:2598-604.CrossRefPubMed Yoshida T, Hibino T, Kako N. A pathophysiologic study of Tako-Tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J 2007;28:2598-604.CrossRefPubMed
13.
Zurück zum Zitat Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003;41:737-42.CrossRefPubMed Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003;41:737-42.CrossRefPubMed
14.
Zurück zum Zitat Feola M, Rossk GL, Casasso F, Morena L, Biggi A, Chauvie S, et al. “reversible inverse-mismatch” in transient left ventricular apical ballooning : perfusion/metabolism positron emission tomography imaging. J Nucl Cardiol 2006;13:587-90.CrossRefPubMed Feola M, Rossk GL, Casasso F, Morena L, Biggi A, Chauvie S, et al. “reversible inverse-mismatch” in transient left ventricular apical ballooning : perfusion/metabolism positron emission tomography imaging. J Nucl Cardiol 2006;13:587-90.CrossRefPubMed
15.
16.
Zurück zum Zitat Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Lusher TF, Camici PG. Coronary artery disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233-8.CrossRefPubMed Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Lusher TF, Camici PG. Coronary artery disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233-8.CrossRefPubMed
17.
Zurück zum Zitat Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Lusher TF, Camici PG. LDL and coronary microvasculature dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-9.CrossRefPubMed Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Lusher TF, Camici PG. LDL and coronary microvasculature dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-9.CrossRefPubMed
18.
Zurück zum Zitat Ito K, Sugihara H, Katoh S, Azuma A, Nakagawa M. Assessment of Takotsubo (ampulla) cardiomyopathy using 99mTc-tetrofosmin myocardial SPECT—comparison with acute coronary syndrome. Ann Nucl Med 2003;17:115-22.CrossRefPubMed Ito K, Sugihara H, Katoh S, Azuma A, Nakagawa M. Assessment of Takotsubo (ampulla) cardiomyopathy using 99mTc-tetrofosmin myocardial SPECT—comparison with acute coronary syndrome. Ann Nucl Med 2003;17:115-22.CrossRefPubMed
19.
Zurück zum Zitat Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. Eur J Nucl Med Mol Imaging 2010;37:737-42. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. Eur J Nucl Med Mol Imaging 2010;37:737-42.
21.
Zurück zum Zitat Christensen TE, Bang LE, Holmvang L, Ghotbi AA, Lassen ML, Andersen F, Ihlemann N, Andersson H, Grande P, Kjaer A, Hasbak P. Cardiac 99mTc sestamibi SPECT and 18F PET as viability markers in takotsubo cardiomyopathy. Int J Cardiovasc Imaging 2014;30:1407-16.CrossRefPubMed Christensen TE, Bang LE, Holmvang L, Ghotbi AA, Lassen ML, Andersen F, Ihlemann N, Andersson H, Grande P, Kjaer A, Hasbak P. Cardiac 99mTc sestamibi SPECT and 18F PET as viability markers in takotsubo cardiomyopathy. Int J Cardiovasc Imaging 2014;30:1407-16.CrossRefPubMed
22.
Zurück zum Zitat Unverferth DV, Lee SV, Wallick ET. Human Myocardial adenosine triphosphatase activities in health and heart failure. Am Heart J 1988;115:139-46.CrossRefPubMed Unverferth DV, Lee SV, Wallick ET. Human Myocardial adenosine triphosphatase activities in health and heart failure. Am Heart J 1988;115:139-46.CrossRefPubMed
23.
Zurück zum Zitat Ito K, Sugihara H, Kinoshita N, Azuma A, Matsubara H. Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT. Ann Nucl Med 2005;19:435-45.CrossRefPubMed Ito K, Sugihara H, Kinoshita N, Azuma A, Matsubara H. Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT. Ann Nucl Med 2005;19:435-45.CrossRefPubMed
24.
Zurück zum Zitat Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48.CrossRefPubMed Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48.CrossRefPubMed
Metadaten
Titel
Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results
verfasst von
Malgorzata Kobylecka, MD, PhD
Monika Budnik, MD
Janusz Kochanowski, MD, PhD
Radoslaw Piatkowski, MD, PhD
Marek Chojnowski, MD
Katarzyna Fronczewska-Wieniawska, MD, PhD
Tomasz Mazurek, MD, PhD
Joanna Maczewska, MD
Michał Peller, MD
Grzegorz Opolski, MD, Prof
Leszek Krolicki, MD, Prof
Publikationsdatum
01.08.2018
Verlag
Springer US
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2018
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0775-x

Weitere Artikel der Ausgabe 4/2018

Journal of Nuclear Cardiology 4/2018 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.